Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/17/2025

Perioperative Management of Mastocytosis

Preoperative Evaluation

  • The American College of Allergy, Asthma, and Immunology recommends that patients with mastocytosis or suspected mast cell disorders should have a baseline tryptase level measured preoperatively to reflect mast cell burden and help interpret subsequent acute elevations 2, 3
  • A baseline tryptase level does not necessarily predict perioperative adverse events, but its knowledge is essential for differential diagnosis if a reaction occurs 2
  • Approximately 5-7% of the population has elevated baseline tryptase without relation to anaphylaxis, including patients with hereditary alpha-tryptasemia 4

Premedication and Prophylaxis

  • The National Comprehensive Cancer Network recommends premedication for most procedures in patients with systemic mastocytosis, as surgery, endoscopy, and other invasive procedures can induce mast cell activation and anaphylaxis 5
  • The use of benzodiazepines, antihistamines (H1 and H2 blockers), and corticosteroids likely helps reduce the frequency and/or severity of mast cell activation symptoms 1
  • Antihistamines H1 (such as cetirizine, diphenhydramine, or hydroxyzine) combined with antihistamines H2 (ranitidine or famotidine) are particularly effective 6
  • Corticosteroids: hydrocortisone 200 mg IV (adult dose) as part of the prophylactic regimen 7

Intraoperative Management

  • The American Society of Anesthesiologists recommends that all patients should have immediate access to epinephrine, with two auto-injectors available for anaphylaxis management 5
  • The risk of anaphylaxis in the perioperative period is higher in patients with systemic mastocytosis compared to the general population 1

Anaphylaxis Management

  • The American Heart Association recommends immediate treatment with epinephrine IM 0.01 mg/kg (1:1000 concentration) in the anterolateral thigh, maximum dose 0.5 mg in adults and 0.3 mg in children, as first-line treatment without absolute contraindications 9
  • Administer oxygen at 100% immediately 9
  • Establish large-caliber IV access and administer rapid boluses of 0.9% saline or Ringer's lactate solution 7, 9

Postoperative Follow-up

  • The American College of Allergy, Asthma, and Immunology recommends that all patients with suspected anaphylactic reactions associated with anesthesia should be fully investigated 7
  • In case of anaphylaxis or other mast cell activation events, initiate a complete allergologic study, including skin tests or detection of specific IgE antibodies to identify IgE-mediated hypersensitivity to drugs 1
  • Refer to a specialized center in Allergy or Immunology with appropriate experience 7

REFERENCES

3

Perioperative Anaphylaxis Diagnosis and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

systemic mastocytosis, version 2.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

5

systemic mastocytosis, version 2.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

6

Management of Mast Cell Activation Disorder in Children [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

Immediate Management of Anaphylaxis with Respiratory Distress [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025